Keywords
brain
cognitive disorders
screening test
dementia
How to Cite
Abstract
In press
This article presents a detailed analysis of key cognitive scales widely used for assessing cognitive functions and diagnosing impairments of varying severity. The study examines the following tools: IQCODE (Informant Questionnaire on Cognitive Decline in the Elderly), CSI "D" (Cognitive Status Interview – Dementia Scale), FAQ (Functional Activities Questionnaire), RPM (Raven’s Progressive Matrices), King-Devick Test, and Oyama A Test. The aim is to compare these tests based on key characteristics such as sensitivity, specificity, ease of use, duration, and cultural adaptability. The IQCODE relies on reports from relatives or caregivers, enabling the assessment of long-term changes in cognitive functions. It is particularly useful for identifying early signs of dementia when patients may not recognize their memory problems. CSI "D" is a standardized interview for diagnosing dementia, evaluating both cognitive and functional status. FAQ assesses daily living activities, helping to determine the level of functional independence and the impact of cognitive decline on daily tasks. RPM is a non-verbal test that measures abstract thinking and problem-solving abilities, making it suitable across diverse cultural and linguistic groups. The King-Devick Test evaluates visual-motor coordination and attention, proving effective in detecting cognitive deficits, particularly after brain injuries. The Oyama A Test offers a comprehensive evaluation of memory, attention, and motor skills, making it useful for identifying early cognitive impairments. The analysis reveals that each test has specific advantages and limitations. The choice of a particular scale should be guided by the study’s goals, patient characteristics, and clinical context. Combining these scales can improve the accuracy of cognitive impairment screening and facilitate early detection, which is vital for timely intervention and enhancing patient outcomes.
Keywords: psychophysiological tests, brain, cognitive disorders, screening test, dementia.
References
Prince M, Wimo A, Guerchet M, Ali GC, Wu YT, Prina M. World Alzheimer Report 2015: The Global Impact of Dementia – An Analysis of Prevalence, Incidence, Cost and Trends. London: Alzheimer’s Disease International; 2015. Available at: https://www.alzint.org/u/WorldAlzheimerReport2015.pdf
Wimo A, Guerchet M, Ali GC, Wu YT, Prina AM, Winblad B, et al. The worldwide costs of dementia 2015 and comparisons with 2010. Alzheimers Dement. 2017;13(1):1-7. DOI: 10.1016/j.jalz.2016.07.150. PMID: 27583652.
Jorm AF. The Informant Questionnaire on cognitive decline in the elderly (IQCODE): a review. Int Psychogeriatr. 2004;16(3):275-93. DOI: 10.1017/s1041610204000390. PMID: 15559753.
Sanchez MA, Lourenco RA. Screening for dementia: Brazilian version of the Informant Questionnaire on Cognitive Decline on the Elderly and its psychometric properties. Geriatr Gerontol Int. 2013;13(3):687-93. DOI: 10.1111/j.1447-0594.2012.00966.x. PMID: 23186020.
Phung TK, Chaaya M, Asmar K, Atweh S, Ghusn H, Khoury RM, et al. Performance of the 16-Item Informant Questionnaire on Cognitive Decline for the Elderly (IQCODE) in an Arabic-Speaking Older Population. Dement Geriatr Cogn Disord. 2015;40(5-6):276-89. DOI: 10.1159/000437092. PMID: 26338716.
Wu Y, Wang Y, Zhang Y, Yuan X, Gao X. A preliminary study of the Saint Louis University Mental Status examination (SLUMS) for the assessment of cognition in moderate to severe traumatic brain injury patients. Appl Neuropsychol Adult. 2023;30(4):409-13. DOI: 10.1080/23279095.2021.1952414. PMID: 34372718.
Potter GG, Plassman BL, Burke JR, Kabeto MU, Langa KM, Llewellyn DJ, et al. Cognitive performance and informant reports in the diagnosis of cognitive impairment and dementia in African Americans and whites. Alzheimers Dement. 2009;5(6):445-53. DOI: 10.1016/j.jalz.2009.04.1234. PMID: 19896583.
Narasimhalu K, Lee J, Auchus AP, Chen CP. Improving detection of dementia in Asian patients with low education: combining the Mini-Mental State Examination and the Informant Questionnaire on Cognitive Decline in the Elderly. Dement Geriatr Cogn Disord. 2008;25(1):17-22. DOI: 10.1159/000111128. PMID: 18025825.
Ding Y, Niu J, Zhang Y, Liu W, Zhou Y, Wei C, Liu Y. Informant questionnaire on cognitive decline in the elderly (IQCODE) for assessing the severity of dementia in patients with Alzheimer's disease. BMC Geriatr. 2018;18(1):146. DOI: 10.1186/s12877-018-0837-9. PMID: 29914396.
Li F, Jia XF, Jia J. The Informant Questionnaire on Cognitive Decline in the Elderly individuals in screening mild cognitive impairment with or without functional impairment. J Geriatr Psychiatry Neurol. 2012;25(4):227-32. DOI: 10.1177/0891988712464822. PMID: 23172761.
Lin JS, O'Connor E, Rossom RC, Perdue LA, Burda BU, Thompson M, et al. Screening for Cognitive Impairment in Older Adults: An Evidence Update for the U.S. Preventive Services Task Force [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Report No.: 14-05198-EF-1. PMID: 24354019.
Prince M, Acosta D, Ferri CP, Guerra M, Huang Y, Jacob KS, et al.; 10/66 Dementia Group. A brief dementia screener suitable for use by non-specialists in resource poor settings--the cross-cultural derivation and validation of the brief Community Screening Instrument for Dementia. Int J Geriatr Psychiatry. 2011;26(9):899-907. DOI: 10.1002/gps.2622. PMID: 21845592.
Hall KS, Gao S, Emsley CL, Ogunniyi AO, Morgan O, Hendrie HC. Community screening interview for dementia (CSI 'D'); performance in five disparate study sites. Int J Geriatr Psychiatry. 2000;15(6):521-31. DOI: 10.1002/1099-1166(200006)15:6<521::aid-gps182>3.0.co;2-f. PMID: 10861918.
Wei X，Hao Z，Chen L，Wang F，Jing L，Xing F. Comparison of the Brief CSI-D and MMSE Scales in Screening for Dementia in Middle-aged and Elderly Chinese People [J]. Chinese General Practice, 2022,25(31):3866-71. Available at: https://www.chinagp.net/EN/abstract/abstract6443.shtml
Jia X, Wang Z, Huang F, Su C, Du W, Jiang H, et al. A comparison of the Mini-Mental State Examination (MMSE) with the Montreal Cognitive Assessment (MoCA) for mild cognitive impairment screening in Chinese middle-aged and older population: a cross-sectional study. BMC Psychiatry. 2021;21(1):485. DOI: 10.1186/s12888-021-03495-6. PMID: 34607584.
Pfeffer RI, Kurosaki TT, Harrah CH Jr, Chance JM, Filos S. Measurement of functional activities in older adults in the community. J Gerontol. 1982;37(3):323-9. DOI: 10.1093/geronj/37.3.323. PMID: 7069156.
Gonzalez DA, Gonzales MM, Resch ZJ, Sullivan AC, Soble JR. Comprehensive Evaluation of the Functional Activities Questionnaire (FAQ) and Its Reliability and Validity. Assessment. 2022;29(4):748-63. DOI: 10.1177/1073191121991215. PMID: 33543638.
Raven J. The Raven's progressive matrices: change and stability over culture and time. Cogn Psychol. 2000;41(1):1-48. DOI: 10.1006/cogp.1999.0735. PMID: 10945921.
Bilker WB, Hansen JA, Brensinger CM, Richard J, Gur RE, Gur RC. Development of abbreviated nine-item forms of the Raven's standard progressive matrices test. Assessment. 2012;19(3):354-69. DOI: 10.1177/1073191112446655. PMID: 22605785.
Langener AM, Kramer AW, van den Bos W, Huizenga HM. A shortened version of Raven's standard progressive matrices for children and adolescents. Br J Dev Psychol. 2022;40(1):35-45. DOI: 10.1111/bjdp.12381. PMID: 34041776.
Kramer AW, van den Bos W, Huizenga HM. A shortened version of Raven's standard progressive matrices for children and adolescents. Br J Dev Psychol. 2022;40(1):35-45. DOI: 10.1111/bjdp.12381. PMID: 34041776.
McDade E, Wang G, Gordon BA, Hassenstab J, Benzinger TLS, Buckles V, et al. Dominantly Inherited Alzheimer Network. Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer disease. Neurology. 2018;91(14):e1295-306. DOI: 10.1212/WNL.0000000000006277. PMID: 30217935.
Wolf A, Ueda K. Contribution of Eye-Tracking to Study Cognitive Impairments Among Clinical Populations. Front Psychol. 2021;12:590986. DOI: 10.3389/fpsyg.2021.590986. PMID: 34163391.
Ionescu A, Stefanescu E, Strilciuc S, Grad DA, Muresanu D. Eyes on dementia: an overview of the interplay between eye movements and cognitive decline. J Med Life. 2023;16(5):642-62. DOI: 10.25122/jml-2023-0217. PMID: 37520470.
Liu Z, Yang Z, Gu Y, Liu H, Wang P. The effectiveness of eye tracking in the diagnosis of cognitive disorders: A systematic review and meta-analysis. PLoS One. 2021;16(7):e0254059. DOI: 10.1371/journal.pone.0254059. PMID: 34252113.
Nguyen CTO, Acosta ML, Di Angelantonio S, Salt TE. Editorial: Seeing Beyond the Eye: The Brain Connection. Front Neurosci. 2021;15:719717. DOI: 10.3389/fnins.2021.719717. PMID: 34267626.
de Oliveira BMR, Nakayama LF, de Godoy BR, de Azevedo AGB, Hirai FE, Mitne S. Reliability of foveal avascular zone measurements in eyes with retinal vein occlusion using optical coherence tomography angiography. Int J Retina Vitreous. 2020;6:35. DOI: 10.1186/s40942-020-00237-w. PMID: 32774887.
Opwonya J, Doan DNT, Kim SG, Kim JI, Ku B, Kim S, et al. Saccadic Eye Movement in Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review and Meta-Analysis. Neuropsychol Rev. 2022;32(2):193-227. DOI: 10.1007/s11065-021-09495-3. PMID: 33959887.
Wilcockson TDW, Mardanbegi D, Xia B, Taylor S, Sawyer P, Gellersen HW, et al. Abnormalities of saccadic eye movements in dementia due to Alzheimer's disease and mild cognitive impairment. Aging (Albany NY). 2019;11(15):5389-98. DOI: 10.18632/aging.102118. PMID: 31375642.
Sun J, Liu Y, Wu H, Jing P, Ji Y. A novel deep learning approach for diagnosing Alzheimer's disease based on eye-tracking data. Front Hum Neurosci. 2022;16:972773. DOI: 10.3389/fnhum.2022.972773. PMID: 36158627.
Gold DM, Rizzo JR, Lee YSC, Childs A, Hudson TE, Martone J, et al. King-Devick Test Performance and Cognitive Dysfunction after Concussion: A Pilot Eye Movement Study. Brain Sci. 2021;11(12):1571. DOI: 10.3390/brainsci11121571. PMID: 34942873.
Lin TP, Adler CH, Hentz JG, Balcer LJ, Galetta SL, Devick S. Slowing of number naming speed by King-Devick test in Parkinson's disease. Parkinsonism Relat Disord. 2014;20(2):226-9. DOI: 10.1016/j.parkreldis.2013.10.009. PMID: 24269283.
Galetta KM, Chapman KR, Essis MD, Alosco ML, Gillard D, Steinberg E, et al. Screening Utility of the King-Devick Test in Mild Cognitive Impairment and Alzheimer Disease Dementia. Alzheimer Dis Assoc Disord. 2017;31(2):152-8. DOI: 10.1097/WAD.0000000000000157. PMID: 27299935.
Oyama A, Takeda S, Ito Y, Nakajima T, Takami Y, Takeya Y, et al. Novel Method for Rapid Assessment of Cognitive Impairment Using High-Performance Eye-Tracking Technology. Sci Rep. 2019;9(1):12932. DOI: 10.1038/s41598-019-49275-x. PMID: 31506486.
Wolf A, Tripanpitak K, Umeda S, Otake-Matsuura M. Eye-tracking paradigms for the assessment of mild cognitive impairment: a systematic review. Front Psychol. 2023;14:1197567. DOI: 10.3389/fpsyg.2023.1197567. PMID: 37546488.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.